Jayodine Biotech Starts Producing Cancer Drug Raw Material for Export

Chitwan. Jayodine Biotech Industry has started producing raw materials for cancer drugs. The industry located in Sharanpur, Bharatpur Metropolitan City-16, has started producing raw materials for cancer drugs by processing Nepali herbs and exporting them to India.

The industry's chairman, Jinaraaj Bahadur Chhetri, informed that "We have started producing and exporting raw materials by installing state-of-the-art equipment." It has been informed that it has come into operation with an investment of Rs 1.30 billion in joint investment of domestic entrepreneurs.

Work is underway in the industry for the production of raw materials and cancer drugs made from them. He said, "We have produced and exported raw materials for cancer drugs."

Cancer drugs have been imported. The industry aims to produce 10-12 types of raw materials. Currently, two raw materials have been produced. From the processed raw material 'Ten Dub Three' from pine bark, raw materials 'Paclitaxel' and 'Docetaxel' have been produced using other chemicals, he said.

Pine bark is processed by Evans Life Science located in Basamadi, Hetauda, and brought here for further processing, he said. After processing, the raw material is ready. Two kilograms five hundred grams of 'Seven Truck Paclitaxel', the prepared raw material, was exported to India on Tuesday.

He said that they have tested the raw material produced by them and obtained permission. He informed that samples were sent to Indian companies for export of raw materials, and after the samples were successful, raw materials were exported to India. This raw material costs between Rs 8 lakh and Rs 25 lakh per kilogram. Raw materials do not have a 'brand' name.

He informed that they have a plan to export to Asian countries including Pakistan and Bangladesh. He informed that pine bark is found in 40 to 45 districts of Nepal and 2 to 3 thousand kilograms of raw material can be produced from 1,500 tons of pine bark annually.

He said that they are also preparing to produce medicines used in the treatment of cancer in another building within the industry.

The industry has the capacity to produce 70 to 80 kg of raw material per month.